GNAL and hypophysitis: Using ELISA, baseline anti-GNAL and elevation of both anti-GNAL and anti-ITM2B antibodies during treatment were shown to be associated with hypophysitis in 20 patients and anti-CD74 antibodies with pneumonitis occurrence in 32 patients with solid tumors (32).